ArticleFrontiers in surgery2026
Discharge-excluded enhanced recovery after surgery adherence and hospital length of stay after laparoscopic hysterectomy for benign disease: a secondary analysis.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: We reassessed the association between enhanced recovery after surgery (ERAS) adherence and hospital length of stay (LOS) after laparoscopic hysterectomy for benign disease after removing discharge timing from the adherence exposure to eliminate direct mathematical overlap with LOS. Methods: This retrospective secondary analysis used routine clinical audit data from 145 adults treated under an ERAS pathway at Nhan Dan Gia Dinh Hospital, Vietnam, during January 2023-June 2024. The previous 15-item audit score was retained descriptively; the primary exposure was a discharge-excluded 14-item score analyzed continuously and as an ordered completion count. Completion count was examined using proportional-odds ordinal logistic regression. LOS was modeled using zero-truncated Poisson regression after comparing Poisson and negative-binomial alternatives. Model-standardized LOS was estimated at five observed completion counts. Results: Mean discharge-excluded adherence was 81.1% ± 5.6% (11.36 ± 0.79 of 14 items), and 144/145 patients were at or above the historical 70% threshold. In the primary ordinal model, documented chronic comorbidity was associated with lower odds of higher completion category (adjusted odds ratio 0.37, 95% CI 0.18-0.76; Conclusion: Higher discharge-excluded ERAS adherence was associated with shorter hospitalization, but the magnitude of the association was sensitive to influential observations, and the phase-specific signal was confined to postoperative adherence. Because postoperative adherence and recovery overlap in time, causal inference is not warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.